Distinguished in Pancreatic Islet Cell Tumor

Susumu Hijioka

Tokyo, JP 
Distinguished in Pancreatic Islet Cell Tumor
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Susumu Hijioka practices in Tokyo, Japan. Mr. Hijioka is rated as a Distinguished expert by MediFind in the treatment of Pancreatic Islet Cell Tumor. His top areas of expertise are Pancreatic Islet Cell Tumor, Pancreatic Cancer, Neuroendocrine Tumor, Endoscopy, and Stent Placement.

His clinical research consists of co-authoring 224 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 24 articles in the study of Pancreatic Islet Cell Tumor.

Gender
Male

Locations

Tokyo, Japan
Other Locations
Chuo, Japan
Chuo, Japan
Nagoya, Japan
Japan
Sawara, 8140001, Japan
Tsukiji, Japan
Okazaki, Japan
Shizuoka, 4118777, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II, Multicenter, Open-label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or Are Intolerant to First-line Platinum-Based Chemotherapy
A Phase II, Multicenter, Open-label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or Are Intolerant to First-line Platinum-Based Chemotherapy
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Drug
Study Drug: M7824
Study Phase: Phase 2

224 Total Publications

Prospective, multicentre trial on preoperative biliary drainage by endoscopic ultrasound-guided hepaticogastrostomy for resectable/borderline resectable pancreatic cancer with biliary obstruction: the PROLOGUE study - a study protocol.
Prospective, multicentre trial on preoperative biliary drainage by endoscopic ultrasound-guided hepaticogastrostomy for resectable/borderline resectable pancreatic cancer with biliary obstruction: the PROLOGUE study - a study protocol.
Journal: BMJ open
Published: October 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hijioka's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 8 Advanced Conditions
    View All 35 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile